4.7 Article

Acetylation of C/EBPε is a prerequisite for terminal neutrophil differentiation

Journal

BLOOD
Volume 125, Issue 11, Pages 1782-1792

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2013-12-543850

Keywords

-

Categories

Funding

  1. Wilhelmina Children's Hospital
  2. Dutch Cancer Foundation
  3. Dutch Rheumatism Foundation

Ask authors/readers for more resources

C/EBP epsilon, a member of the CCAAT/enhancer binding protein (C/EBP) family of transcription factors, is exclusively expressed in myeloid cells and regulates transition from the promyelocytic stage to the myelocytic stage of neutrophil development, being indispensable for secondary and tertiary granule formation. Knowledge concerning the functional role of C/EBP epsilon posttranslational modifications is limited to studies concerning phosphorylation and sumoylation. In the current study, using ectopic expression and ex vivo differentiation of CD34(+) hematopoietic progenitor cells, we demonstrate that C/EBP epsilon is acetylated, which was confirmed by mass spectrometry analysis, identifying 4 acetylated lysines in 3 distinct functional domains. Regulation of C/EBP epsilon acetylation levels by the p300 acetyltransferase and the sirtuin 1 deacetylase controls transcriptional activity, which can at least in part be explained by modulation of DNA binding. During neutrophil development, acetylation of lysines 121 and 198 were found to be crucial for terminal neutrophil differentiation and the expression of neutrophil-specific granule proteins, including lactoferrin and collagenase. Taken together, our data illustrate a critical role for acetylation in the functional regulation of C/EBP epsilon activity during terminal neutrophil development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

SUGAR-seq enables simultaneous detection of glycans, epitopes, and the transcriptome in single cells

Conor J. Kearney, Stephin J. Vervoort, Kelly M. Ramsbottom, Izabela Todorovski, Emily J. Lelliott, Magnus Zethoven, Lizzy Pijpers, Ben P. Martin, Timothy Semple, Luciano Martelotto, Joseph A. Trapani, Ian A. Parish, Nichollas E. Scott, Jane Oliaro, Ricky W. Johnstone

Summary: SUGAR-seq is a novel method that enables simultaneous detection of N-linked glycosylation, extracellular epitopes, and the transcriptome at the single-cell level, providing insights into cellular differentiation states. Integrated analysis using SUGAR-seq and glycoproteome identified tumor-infiltrating T cells with unique surface glycan properties that reflect their epigenetic and functional state.

SCIENCE ADVANCES (2021)

Review Cell Biology

Tissue-Resident Memory T Cells in Chronic Inflammation-Local Cells with Systemic Effects?

Anoushka Ashok Kumar Samat, Jolijn van der Geest, Sebastiaan J. Vastert, Jorg van Loosdregt, Femke van Wijk

Summary: The article summarizes the role of tissue-resident memory T cells (T-RM) in chronic inflammatory diseases, highlighting the presence of T-RM in both non-lymphoid tissue and circulation, and their potential significance in disease progression and treatment.

CELLS (2021)

Article Biochemistry & Molecular Biology

The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer

Stephin J. Vervoort, Sarah A. Welsh, Jennifer R. Devlin, Elisa Barbieri, Deborah A. Knight, Sarah Offley, Stefan Bjelosevic, Matteo Costacurta, Izabela Todorovski, Conor J. Kearney, Jarrod J. Sandow, Zheng Fan, Benjamin Blyth, Victoria McLeod, Joseph H. A. Vissers, Karolina Pavic, Ben P. Martin, Gareth Gregory, Elena Demosthenous, Magnus Zethoven, Isabella Y. Kong, Edwin D. Hawkins, Simon J. Hogg, Madison J. Kelly, Andrea Newbold, Kaylene J. Simpson, Otto Kauko, Kieran F. Harvey, Michael Ohlmeyer, Jukka Westermarck, Nathanael Gray, Alessandro Gardini, Ricky W. Johnstone

Summary: CDK9 regulates gene expression by controlling the pausing checkpoint during the transcription cycle, while PP2A counteracts CDK9-mediated phosphorylation. Loss of INTS6 leads to resistance to CDK9 inhibition-induced tumor cell death, and pharmacological activation of PP2A in combination with CDK9 inhibition provides therapeutic benefits in vivo.
Article Pediatrics

Dutch patients, caregivers and healthcare professionals generate first nationwide research agenda for juvenile idiopathic arthritis

Anouk Verwoerd, Wineke Armbrust, Katherine Cowan, Lotte van den Berg, Joke de Boer, Sanne Bookelman, Marjan Britstra, Jeannette Cappon, Maria Certan, Christine Dedding, Karin van den Haspel, Petra Hissink Muller, Karin Jongsma, Otto Lelieveld, Jorg van Loosdregt, Wendy Olsder, Johanna Rocha, Ellen Schatorje, Natasja Schouten, Joost F. Swart, Sebastiaan Vastert, Margot Walter, Casper G. Schoemaker

Summary: Involving end-users in setting research priorities is crucial to ensure research questions align with patient needs. This study aimed to generate a national research agenda for Juvenile Idiopathic Arthritis (JIA) with patients, caregivers, and clinicians. Through a nationwide survey and focus groups, the top 10 research priorities were identified, focusing on pain, fatigue, personalized treatment strategies, and etiology.

PEDIATRIC RHEUMATOLOGY (2021)

Article Multidisciplinary Sciences

Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation

Gerdien Mijnheer, Lisanne Lutter, Michal Mokry, Marlot van der Wal, Rianne Scholman, Veerle Fleskens, Aridaman Pandit, Weiyang Tao, Mark Wekking, Stephin Vervoort, Ceri Roberts, Alessandra Petrelli, Janneke G. C. Peeters, Marthe Knijff, Sytze de Roock, Sebastiaan Vastert, Leonie S. Taams, Jorg van Loosdregt, Femke van Wijk

Summary: The study illustrates the effector characteristics of human Treg cells under inflammatory conditions and their epigenetic influences, indicating that inflammation-derived Treg cells have specific features and are fine-tuned by environmental adaptations.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance

Mayura Wagle, Stephin J. Vervoort, Madison J. Kelly, Willem Van der Byl, Timothy J. Peters, Ben P. Martin, Luciano G. Martelotto, Simone Nuessing, Kelly M. Ramsbottom, James R. Torpy, Deborah Knight, Sinead Reading, Kevin Thia, Lisa A. Miosge, Debbie R. Howard, Renee Gloury, Sarah S. Gabriel, Daniel T. Utzschneider, Jane Oliaro, Jonathan D. Powell, Fabio Luciani, Joseph A. Trapani, Ricky W. Johnstone, Axel Kallies, Christopher C. Goodnow, Ian A. Parish

Summary: Chronic antigenic stimulation induces the expression of EGR2, which in turn affects the epigenetic and transcriptional identity of exhausted T cells.

NATURE COMMUNICATIONS (2021)

Article Oncology

CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory

Emily J. Lelliott, Isabella Y. Kong, Magnus Zethoven, Kelly M. Ramsbottom, Luciano G. Martelotto, Deborah Meyran, Joe Jiang Zhu, Matteo Costacurta, Laura Kirby, Jarrod J. Sandow, Lydia Lim, Pilar M. Dominguez, Izabela Todorovski, Nicole M. Haynes, Paul A. Beavis, Paul J. Neeson, Edwin D. Hawkins, Grant A. McArthur, Ian A. Parish, Ricky W. Johnstone, Jane Oliaro, Karen E. Sheppard, Conor J. Kearney, Stephin J. Vervoort

Summary: Pharmacologic inhibitors of CDK4/6 have been shown to not only have well-defined tumor-intrinsic cytostatic mechanisms, but also promote the acquisition of immunologic T-cell memory. These insights significantly broaden the potential utility of CDK4/6 inhibitors as clinical tools to boost antitumor T-cell immunity.

CANCER DISCOVERY (2021)

Article Dermatology

ZFP36 Family Members Regulate the Proinflammatory Features of Psoriatic Dermal Fibroblasts

Chiara Angiolilli, Emmerik F. A. Leijten, Cornelis P. J. Bekker, Ella Eeftink, Barbara Giovannone, Michel Olde Nordkamp, Marlot van der Wal, Judith L. Thijs, Sebastiaan J. Vastert, Femke van Wijk, Timothy R. D. J. Radstake, Jorg van Loosdregt

Summary: Dermal fibroblasts in psoriatic skin are important producers of inflammatory mediators, and their cytokine production is regulated by ZFP36 family members. The expression of ZFP36 family proteins is reduced in chronic inflammatory conditions that mimic psoriatic skin.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Oncology

BET Inhibition Enhances TNF-Mediated Antitumor Immunity

Lisa C. Wellinger, Simon J. Hogg, Dane M. Newman, Thomas Friess, Daniela Geiss, Jessica Michie, Kelly M. Ramsbottom, Marina Bacac, Tanja Fauti, Daniel Marbach, Laura Jarassier, Phillip Thienger, Axel Paehler, Leonie A. Cluse, Conor J. Kearney, Stephin J. Vervoort, Joseph A. Trapani, Jane Oliaro, Jake Shortt, Astrid Ruefli-Brasse, Daniel Rohle, Ricky W. Johnstone

Summary: Targeting chromatin binding proteins and modifying enzymes can enhance antitumor immunity and effectiveness of cancer immunotherapies by affecting tumor cell proliferation and survival. BET inhibitors sensitize tumor cells to TNF-induced cell death and suppress inflammatory gene expression, leading to enhanced tumor growth inhibition in combination with T-cell bispecific antibodies or immune-checkpoint blockade.

CANCER IMMUNOLOGY RESEARCH (2022)

Article Rheumatology

Epigenetic changes in inflammatory arthritis monocytes contribute to disease and can be targeted by JAK inhibition

Janneke G. C. Peeters, Arjan Boltjes, Rianne C. Scholman, Stephin J. Vervoort, Paul J. Coffer, Michal Mokry, Sebastiaan J. Vastert, Femke van Wijk, Jorg van Loosdregt

Summary: This study investigates the epigenetic changes in monocytes derived from inflamed joints of JIA patients and reveals the role of the local inflammatory environment in regulating these changes. The activation phenotype of synovial-derived monocytes is found to be regulated on the epigenetic level, with increased expression and epigenetic alterations in IFN signaling-associated genes. Treatment with the JAK inhibitor ruxolitinib transforms the activated enhancer landscape and reduces disease-associated gene expression, thus inhibiting the inflammatory phenotype.

RHEUMATOLOGY (2023)

Article Immunology

Conventional dendritic cells type 1 are strongly enriched, quiescent and relatively tolerogenic in local inflammatory arthritis

Arjan Boltjes, Anoushka Ashok Kumar Samat, Maud Plantinga, Michal Mokry, Bas Castelijns, Joost F. Swart, Sebastiaan J. Vastert, Menno Creyghton, Stefan Nierkens, Jorg van Loosdregt, Femke van Wijk

Summary: This study indicates that human dendritic cells (DCs) have specific functional programming in chronic inflammatory conditions. Compared to other cell types, cDC1 remains relatively quiescent and unchanged at the site of inflammation, while cDC2 and monocytes show stronger inflammatory features and T cell activation ability.

FRONTIERS IN IMMUNOLOGY (2023)

Article Biochemistry & Molecular Biology

NRF2/Itaconate Axis Regulates Metabolism and Inflammatory Properties of T Cells in Children with JIA

Anandhi Rajendiran, Sudheendra Hebbar Subramanyam, Patricia Klemm, Vera Jankowski, Jorg van Loosdregt, Bas Vastert, Kristina Vollbach, Norbert Wagner, Klaus Tenbrock, Kim Ohl

Summary: This study investigated the behavior of CD4+ T cells in the inflamed joints of patients with childhood rheumatism. It found that CD4+ T cells adapt to hypoxia, oxidative stress, and reduction in nutrients in the inflammatory environment, showing a high metabolic status and increased oxidative stress. The study also identified the potential role of NRF2 in regulating CD4+ T cells.

ANTIOXIDANTS (2022)

Article Immunology

Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic joint

Lisanne Lutter, M. Marlot van der Wal, Eelco C. Brand, Patrick Maschmeyer, Sebastiaan Vastert, Mir-Farzin Mashreghi, Jorg van Loosdregt, Femke van Wijk

Summary: The study reveals a heterogeneous population of Tregs at the site of inflammation in patients with juvenile idiopathic arthritis. Synovial fluid Tregs differentiate into a classical eTreg profile, with some showing a more dominant suppressive or cytotoxic profile, while others differentiate into Tregs with unique features. Key regulators identified in driving Treg adaptation at inflamed joints may be potential targets for autoimmune or tumor interventions.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition

Simon J. Hogg, Olga Motorna, Leonie A. Cluse, Timothy M. Johanson, Hannah D. Coughlan, Ramya Raviram, Robert M. Myers, Matteo Costacurta, Izabela Todorovski, Lizzy Pijpers, Stefan Bjelosevic, Tobias Williams, Shannon N. Huskins, Conor J. Kearney, Jennifer R. Devlin, Zheng Fan, Jafar S. Jabbari, Ben P. Martin, Mohamed Fareh, Madison J. Kelly, Daphne Dupere-Richer, Jarrod J. Sandow, Breon Feran, Deborah Knight, Tiffany Khong, Andrew Spencer, Simon J. Harrison, Gareth Gregory, Vihandha O. Wickramasinghe, Andrew Webb, Phillippa C. Taberlay, Kenneth D. Bromberg, Albert Lai, Anthony T. Papenfuss, Gordon K. Smyth, Rhys S. Allan, Jonathan D. Licht, Dan A. Landau, Omar Abdel-Wahab, Jake Shortt, Stephin J. Vervoort, Ricky W. Johnstone

Summary: The study found that catalytic inhibition of P300/CBP dynamically disrupts steady-state acetylation kinetics and suppresses oncogenic transcriptional networks without changing chromatin accessibility. CRISPR-Cas9 screening identified NCOR1 and HDAC3 as the key antagonists of P300/CBP by counteracting acetylation turnover kinetics. Deacetylation of H3K27 provides nucleation sites for reciprocal methylation switching, which can be therapeutically exploited by simultaneous KDM6A and P300/CBP inhibition.

MOLECULAR CELL (2021)

No Data Available